FRANK E. THOMAS - Director at Larimar Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
LRMR on Nasdaq
All Insider Reports
All Insider Reports

FRANK E. THOMAS - trading volume in the past year for Larimar Therapeutics, Inc.

Holdings reported by FRANK E. THOMAS for Larimar Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7,000 $35,000 $5.00 27 Feb 2026 Direct
Stock Option (Right to Buy) 19,000 13 May 2025 Direct Common Stock

Transactions reported by FRANK E. THOMAS for Larimar Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.